ABR

17 05 '22

RISE Content Remains Important Part of Qualifying, Certifying Exams

Although the ABR will discontinue including Authorized User Eligible (AU-E) designations on certificates issued after December 31, 2023, all candidates and program directors should be aware that radioisotope safety items will continue to be tested on the Qualifying (Core) and Certifying (essentials module) exams. The type and number of items will remain the same…

12 05 '22

Call for Stakeholder Comment Regarding Diagnostic Radiology Initial Certification

Background & Goals As we near a decade since making major modifications to the American Board of Radiology (ABR) Diagnostic Radiology (DR) Initial Certification (IC) process, we are seeking stakeholder input and insights into the process, with the goal of continuous improvement. This review includes both the Qualifying (Core) and Certifying exams. At…

10 05 '22

Med Student Preparing for Match 2023 and Beyond

By Emmanuel Jnr Amoateng In August 2019, Match 2023 felt like a distant goal. I had all the time in the world to prepare. Match 2022 gave me a reality check. I knew my opportunity was coming in less than a year. Graduating medical school is an accomplishment, but within the medical community,…

Page 1 of 831 2 3 … 83 Next

Privacy & Legal |

Americans with Disabilities Act (ADA)

The American Board of Radiology does not and shall not discriminate based on race, color, religion (creed), gender, gender expression, age, national origin (ancestry), disability, marital status, sexual orientation, or military status in any of its activities or operations. These activities include but are not limited to hiring and firing of staff, selection of volunteers, conducting committee meetings, and administering exams. We are committed to an environment free from discrimination, sexual harassment, and other unlawful forms of harassment. To report any actions of discrimination, sexual harassment, or other unlawful harassment, please contact Karyn Howard, Managing Director, at 520-790-2900 extension 2171 or you can call our confidential hotline at 844-280-0005.

Version: 3.0.41

